CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+12.33%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.6B
AUM Growth
+$1.15B
(+7.9%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
755
New
44
Increased
354
Reduced
220
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
$80.1M |
| 2 |
Salesforce
CRM
|
$55.1M |
| 3 |
Micron Technology
MU
|
$53.8M |
| 4 |
Apple
AAPL
|
$50M |
| 5 |
Applied Materials
AMAT
|
$48.3M |
Top Sells
| 1 |
Merck
MRK
|
$73.5M |
| 2 |
ANSS
Ansys
ANSS
|
$53.4M |
| 3 |
Adobe
ADBE
|
$51.7M |
| 4 |
TJX Companies
TJX
|
$41.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
$39.6M |
Sector Composition
| 1 | Technology | 31.73% |
| 2 | Healthcare | 28.37% |
| 3 | Financials | 8.73% |
| 4 | Consumer Discretionary | 8.29% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Arcellx
ACLX
$4.03B
| $15.3M | 0.1% |
220,008
-62,005
| -22% | -$4.31M |
|
202
Annaly Capital Management
NLY
$14.2B
| $15.2M | 0.1% |
770,504
+369,730
| +92% | +$7.28M |
|
203
Iron Mountain
IRM
$27.2B
| $15.1M | 0.1% |
188,448
+144,529
| +329% | +$11.6M |
|
204
Ascendis Pharma
ASND
$12.5B
| $15M | 0.1% |
99,375
| – | – |
|
205
argenx
ARGX
$45.9B
| $15M | 0.1% |
+38,153
| New | +$15M |
|
206
Veracyte
VCYT
$2.55B
| $14.9M | 0.1% |
670,937
+60,005
| +10% | +$1.33M |
|
207
Moody's
MCO
$89.5B
| $14.8M | 0.09% |
37,705
+14,908
| +65% | +$5.86M |
|
208
BioNTech
BNTX
$27B
| $14.8M | 0.09% |
160,303
+120,000
| +298% | +$11.1M |
|
209
TriNet
TNET
$3.43B
| $14.4M | 0.09% |
108,843
+10,104
| +10% | +$1.34M |
|
210
Xencor
XNCR
$610M
| $14.4M | 0.09% |
651,317
-56,667
| -8% | -$1.25M |
|
211
IDEX
IEX
$12.4B
| $14.3M | 0.09% |
58,640
+8,374
| +17% | +$2.04M |
|
212
Target
TGT
$42.3B
| $14.2M | 0.09% |
80,261
+19,774
| +33% | +$3.5M |
|
213
Kura Oncology
KURA
$713M
| $13.9M | 0.09% |
651,417
+110,000
| +20% | +$2.35M |
|
214
Jabil
JBL
$22.5B
| $13.8M | 0.09% |
103,312
-47,511
| -32% | -$6.36M |
|
215
Idexx Laboratories
IDXX
$51.4B
| $13.8M | 0.09% |
25,538
-9,098
| -26% | -$4.91M |
|
216
M&T Bank
MTB
$31.2B
| $13.7M | 0.09% |
93,943
+7,989
| +9% | +$1.16M |
|
217
eBay
EBAY
$42.3B
| $13.6M | 0.09% |
257,492
-154,857
| -38% | -$8.17M |
|
218
Exact Sciences
EXAS
$10.2B
| $13.6M | 0.09% |
196,753
-81,917
| -29% | -$5.66M |
|
219
Kanzhun
BZ
$11.1B
| $13.4M | 0.09% |
767,000
-1,390,254
| -64% | -$24.4M |
|
220
Celldex Therapeutics
CLDX
$1.52B
| $13.3M | 0.09% |
317,509
| – | – |
|
221
Kymera Therapeutics
KYMR
$3.11B
| $13.2M | 0.08% |
328,302
-15,000
| -4% | -$603K |
|
222
CarMax
KMX
$9.11B
| $13.2M | 0.08% |
151,169
+17,651
| +13% | +$1.54M |
|
223
Nurix Therapeutics
NRIX
$758M
| $13.1M | 0.08% |
892,110
-26,000
| -3% | -$382K |
|
224
Ameresco
AMRC
$1.37B
| $13M | 0.08% |
538,027
+16
| +0% | +$386 |
|
225
Marsh & McLennan
MMC
$100B
| $12.8M | 0.08% |
59,555
+3,524
| +6% | +$759K |
|